Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands (scientific article)

What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data

Q34680149

Disubstituted 1-Aryl-4-Aminopiperidine Library Synthesis Using Computational Drug Design and High-Throughput Batch and Flow Technologies

Q34910444

Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for 'Orphan' Molecules

Q37094597

Integrated extended-nano chemical systems on a chip

Q37697537

Advances in microfluidics for drug discovery

Q38029121

Imidazolopiperazines: hit to lead optimization of new antimalarial agents.

Q39530026

N-Fused Imidazoles As Novel Anticancer Agents That Inhibit Catalytic Activity of Topoisomerase IIα and Induce Apoptosis in G1/S Phase

Q39530047

Quantifying the chemical beauty of drugs.

Q42414958

From machine learning to natural product derivatives that selectively activate transcription factor PPARgamma

Q43204326

Impact of high-throughput screening in biomedical research

Q45352809

ChemDB update--full-text search and virtual chemical space.

Q46257274

Evaluating virtual screening methods: good and bad metrics for the "early recognition" problem

Q51922697

The ?-Addition of Immonium Ions and Anions to Isonitriles Accompanied by Secondary Reactions

Q56430542

Multicomponent Reactions as a Powerful Tool for Generic Drug Synthesis

Q56815732

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

G protein-coupled receptor

Q38173

P304

page(s)

582-585

P577

publication date

2013-11-26

P1433

published in

Angewandte Chemie International Edition

Q62023953

P1476

title

Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands

P478

volume

Reverse relations

cites work (P2860)

Q38209736	Accessing new chemical entities through microfluidic systems
Q38750215	Active learning for computational chemogenomics
Q47780833	Automating drug discovery
Q38843130	Counting on natural products for drug design
Q36095417	Designing Multi-target Compound Libraries with Gaussian Process Models
Q27300835	Efficient isocyanide-less isocyanide-based multicomponent reactions
Q92219664	Exploiting the Nucleophilicity of the Nitrogen Atom of Imidazoles: One-Pot Three-Component Synthesis of Imidazo-Pyrazines
Q39184034	Future De Novo Drug Design
Q47626065	Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point
Q90429639	Machine Learning Uncovers Food- and Excipient-Drug Interactions
Q36138895	Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening
Q61218037	Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors
Q45957534	Multi-objective molecular de novo design by adaptive fragment prioritization.
Q62496001	Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Q37140411	New paradigms in GPCR drug discovery.
Q38828670	Optimization of TRPV6 Calcium Channel Inhibitors Using a 3D Ligand-Based Virtual Screening Method
Q54152494	Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects
Q30086274	Proteochemometric modeling in a Bayesian framework
Q34674736	Rhodium-catalyzed NH insertion of pyridyl carbenes derived from pyridotriazoles: a general and efficient approach to 2-picolylamines and imidazo[1,5-a]pyridines